|
 News
Customer
Stories
About
Us
Contacts
|
 STARLIMS
Announces Exercise of Over-
allotment Option by Underwriters
Offering Results in Total Net Proceeds
for the Company of $27 Million
Hollywood, Florida, June 27, 2007 –
STARLIMS Technologies Ltd. (NASDAQ: LIMS) today announced that
in connection with the company’s May 2007 initial public
offering in the United States, Oppenheimer & Co. and JMP
Securities LLC have exercised part of their over-allotment
option and have purchased an additional 126,300 ordinary shares
from the company.
STARLIMS has sold a total of 2,226,300
ordinary shares (including the over-allotment option shares) at
a price to the public of $13.50 per share, resulting in net
proceeds from the offering of approximately US $27 million.
Oppenheimer & Co. is acting as sole
bookrunning manager of the offering and JMP Securities LLC is
acting as co-lead manager of the offering. This offering of
ordinary shares is being made only by means of a prospectus.
Copies of the final prospectus may be obtained from Oppenheimer
& Co. Inc. at 125 Broad Street, 16th Floor, New York, New York
10004 and JMP Securities LLC at 600 Montgomery Street, Suite
1100, San Francisco, California 94111.
This press release shall not constitute an
offer to sell or a solicitation of an offer to buy, nor will
there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
 About
STARLIMS
STARLIMS Technologies Ltd. (NASDAQ: LIMS) is
a leading provider of laboratory information management systems
(LIMS), with over 20 years of LIMS experience. The company's
flagship product, STARLIMS®, improves the reliability of
laboratory sampling processes, supports compliance with domestic
and international regulations and industry standards, and
provides comprehensive reporting, monitoring and analysis
capabilities. STARLIMS software is used for quality assurance
and control, testing and monitoring, and research and
development in government, manufacturing and life sciences
organizations. With operations in the United States, Canada, the
United Kingdom, Israel and Hong Kong, the company serves over
500 organizations in 40 countries. Please see
www.starlims.com for more
information
### |
|
